Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Cash & Current Investments (2020 - 2025)

Agilon Health (AGL) has disclosed Cash & Current Investments for 6 consecutive years, with $285.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments fell 28.71% year-over-year to $285.1 million, compared with a TTM value of $285.1 million through Dec 2025, down 28.71%, and an annual FY2025 reading of $285.1 million, down 28.71% over the prior year.
  • Cash & Current Investments was $285.1 million for Q4 2025 at Agilon Health, up from $139.2 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $1.1 billion in Q2 2021 and bottomed at $105.3 million in Q1 2021.
  • Average Cash & Current Investments over 5 years is $595.6 million, with a median of $444.7 million recorded in 2023.
  • The sharpest move saw Cash & Current Investments surged 873.86% in 2021, then plummeted 64.58% in 2025.
  • Year by year, Cash & Current Investments stood at $1.0 billion in 2021, then decreased by 15.66% to $877.2 million in 2022, then crashed by 44.33% to $488.3 million in 2023, then decreased by 18.1% to $400.0 million in 2024, then dropped by 28.71% to $285.1 million in 2025.
  • Business Quant data shows Cash & Current Investments for AGL at $285.1 million in Q4 2025, $139.2 million in Q3 2025, and $327.0 million in Q2 2025.